Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they ...

Britain on Monday asked its antitrust regulator to make growth and investment a priority as the government sought to woo some ...

If you're looking for two magnificent growth stocks to start your long-term portfolio (or add to a portfolio) and have $500 ...

Chief Executive David Ricks told then-UK Health Secretary Victoria Atkins last December that the company’s new Alzheimer’s ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

A summary of recent health news includes HIV transmission via organ transplants in Brazil, a reconsideration of Eli Lilly's ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Recent health news includes the FDA reconsidering its stance on compounded drugs, Australia's investment against bird flu, ...

Report on how AI is redefining market landscape - The Global Gastrointestinal Diseases Therapeutics Market size is es ...

Billions of pounds worth of investments in emerging growth sectors are set to be unveiled by businesses and ministers at the ...

With faster earnings growth expected for the 4Q and 2025, more attention will likely be paid to earnings guidance.